Genetic research

Genetic research

Letermovir Proven Safe and Efficacious for Preventing CMV Reactivation in Pediatric Patients Undergoing HSCT

Pediatric patients undergoing hematopoietic stem cell transplant (HSCT) are at risk of developing cytomegalovirus (CMV) reactivation. A recent study published in the Transplantation and Cellular Therapy journal investigated the use of letermovir, a viral terminate inhibitor, for primary and secondary prophylaxis of CMV reactivation in pediatric patients. The study aimed

Genetic research

Efficacy of Standard Cytotoxic Drugs in Head and Neck Squamous Cell Carcinoma Limited Due to Multidrug Resistance

Researchers at Heidelberg University have published a study in the journal Toxicology and Applied Pharmacology, highlighting the limited efficacy of standard cytotoxic drugs against head and neck squamous cell carcinoma (HNSCC) due to multidrug resistance (MDR). The study demonstrates that the aryl hydrocarbon receptor (AhR) signaling pathway is active in